Social Media Ideas for #Chikungunyavaccine

Dengue vaccine to hit market by first half of 2027

Doctors urged to test for chikungunya as Hong Kong detects first local 2026 case

Doctors in Hong Kong have been urged to arrange blood tests for patients with symptoms of chikungunya fever, regardless of their travel history, after the city recorded its first l...

Chikungunya: Η νέα… εξωτική απειλή που έφεραν τα κουνούπια

Δεκάδες κρούσματα του ιού έχουν καταγραφεί στη Γαλλία, ενώ παράλληλα έχουν εντοπιστεί πέντε κρούσματα δάγκειου πυρετού

VaxThera and Codagenix Partner to Advance a Next Generation Yellow Fever Vaccine

VaxThera will further advance Syn17D-YF, the world's first fully synthetic yellow fever vaccine candidate designed for modern cell-culture manufacturing

Takeda’s Qdenga dengue vaccine to be distributed in India by Dr Reddy’s in 2027

Takeda has an existing supply agreement with Biological E, as part of its strategy to improve access to dengue-endemic countries

PAHO Urges Caribbean to Prepare for Possible Dengue and Chikungunya Surge

Caribbean countries are being urged to strengthen disease monitoring and prepare their health services for […] The post PAHO Urges Caribbean to Prepare for Possible Dengue and Chik...

DRC begins new vaccine trial as outbreak kills over 4,600

The trial, named Tumaini, which means “hope” in Swahili, will assess vaccine candidates designed to protect against the Bundibugyo virus, for which no vaccine has been approved The...

80 lakh HPV vaccine doses given since February launch

New hope for TB prevention in people with HIV as experimental vaccine deemed safe

THE experimental M72/AS01 tuberculosis (TB) vaccine has shown a favourable safety profile in people living with HIV who are on antiretroviral therapy (ART), boosting prospects for...

Trial of experimental Parkinson’s vaccine shows positive initial results

ACI-7104, AC Immune’s experimental vaccine for early Parkinson’s disease, was generally safe and triggered an immune response against aggregated alpha-synuclein, according to resul...

Bharat Biotech slashes malaria vaccine price on GAVI-backed pact with UNICEF

Malaria parasite ‘Achilles’ heel’ could pave way for new vaccine

"This is truly a game-changing, paradigm-shifting discovery."

ICMR says Southern Hemisphere flu vaccine can be used amid shortage

India’s premier medical research body has advised people to use a Southern Hemisphere(SM) flu vaccine, as supplies of the preferred Northern Hemisphere(NH) formulation are limited...

Hackensack Meridian CDI awarded $2.5M to combat mosquito-borne flaviviruses

Scientists at the Hackensack Meridian Center for Discovery and Innovation (CDI), in collaboration with Gilead Sciences and The Rockefeller University, secured a $2.5 million grant...

Uganda trials Ebola vaccine as countries rush to tame spread

Phase One trial involves an experimental vaccine candidate known as ChAdOx1 BDBV. It's being conducted by Ugandan researchers alongside colleagues from London and University of Oxf...

Congo-Kinshasa: Ebola Vaccine Trials 'Reason for Hope' in DR Congo and Beyond

[RFI] Five months into the Ebola outbreak in the Democratic Republic of Congo, there is still no approved vaccine against the rare Bundibugyo strain that has now caused more than 4...

Interest In Dementia Vaccine High In U.S., Survey Finds

TUESDAY, Sept. 22, 2026 — Americans’ skepticism of vaccines does not appear to extend to brain health, a new study says. Nearly 3 out of 4 U.S. middle-aged people and seniors say t...

Adjuvant duo CpG 1018 and alum supercharges N2 flu vaccine immunity

Two Classic Adjuvants, One Powerful Punch: CpG 1018 and Alum Supercharge Immunity to an N2 Neuraminidase Flu Vaccine For nearly a century, influenza vaccine design has been a love...

कोरोना के नए खतरे से निपटने की तैयारी तेज

नई दिल्ली। कोरोना वायरस के नए वैरिएंट से निपटने के लिए भारत में वैक्सीन को अपडेट करने की दिशा में महत्वपूर्ण कदम उठाया गया है। बायोलॉजिकल-ई कंपनी की कॉर्बेवैक्स वैक्सीन को ओमिक्रॉन...

New Tumaini Ebola vaccine trial launches in Bunia as DRC struggles

A clinical trial for a new Ebola vaccine is getting underway in DR Congo’s Ituri province. The TUMAini trial will evaluate candidate vaccines against the Bundibugyo strain of the v...

Melanoma Vaccine Ushers in New Hope for Cancer Patients

Beyond melanoma, scientists are studying cancer vaccines for glioblastoma, pancreatic cancer and more.

Ebola vaccine trial begins in DR Congo

GENEVA, Switzerland—The first clinical trial of an Ebola vaccine in the outbreak gripping the Democratic Republic of Congo began Friday, the head of the World Health Organization s...

Oxford-developed Ebola vaccine administered to volunteers in Uganda

Ugandan participants in a clinical safety study received an Oxford-developed Ebola vaccine last week.

Two Japanese Encephalitis Vaccines Can Be Safely Mixed, Landmark Indian Trial Finds

A phase 4 randomized trial across five Indian hospitals shows that the inactivated Japanese encephalitis vaccines JENVAC and JEEV can be safely interchanged in the two-dose childho...